CV Issue 2 2018

38 CORPORATE VISION / Issue 2 2018 care solutions for the future. Consequently, it materializes towards our global partners, showing them loyalty, absolute ethics and both operational and development support of advanced, go to market strategies.” The convergence of these three well-defined areas make up the Sintetica Value Proposition. It is a distinctive and strategic element of their own identity in the wide world panorama of the pharmaceutical industry. Moving forward, the company is eager to build upon its current success and continue to deliver innovative and vital solutions to its global partners and clients, as Augusto is proud to conclude. “Ultimately, at Sintetica, we have built up our international network and have done most of the legwork to register our products in over 100 different countries, and over the next five years we should see these efforts bear fruit and our products launched in many of these countries. Thus, with network of partners who share our ‘quality first’ value we should be able to maintain and expand our current innovation driven value proposition significantly over the coming five years. “Another crucial future development for our firm is that we have a radical innovation in the field of pain relief after surgery, which is currently under final stages of development. The potential of this innovation could be disruptive all over the world and could enhance the way pain is managed in hospital and at home after surgery. As such, it is my opinion that Sintetica will continue to flourish as we look towards a bright and exciting future.” Company: Sintetica S.A. Contact: Augusto Mitidieri Contact Email: [email protected] Address: Via Penate 5, Mendrisio, 6850, Switzerland Phone: 41916404250 Website: http://sintetica.com/